Evan Lippman insider trades
Open-market stock purchases and sales by Evan Lippman, EVP, Business Development at Teva Pharmaceutical Industries Ltd, from SEC Form 4 filings since May 14, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 14, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Sold | $204K |
| May 14, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Sold | $1.3M |
| May 14, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
| May 14, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
| Mar 4, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
Companies traded
- TEVA Teva Pharmaceutical Industries Ltd: 2 sales, last May 14, 2026